Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation
Xu Zhou,1 Jun Chen,2 Hua Tao,1,2 Yujie Cai,1 Lidan Huang,1 Haihong Zhou,2 Yanyan Chen,1 Lili Cui,1 Wangtao Zhong,2 Keshen Li3 1Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, People’s R...
Guardado en:
Autores principales: | Zhou X, Chen J, Tao H, Cai Y, Huang L, Zhou H, Chen Y, Cui L, Zhong W, Li K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/447d35c98f534a1abdf3b8291ac4597e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus
por: Yu A, et al.
Publicado: (2017) -
MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a
por: Liu XX, et al.
Publicado: (2017) -
Formulación de metoclopramida en partículas poliméricas mucoadhesivas para administración intranasal
por: Vargas-Fresneda,Marcela, et al.
Publicado: (2020) -
Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration
por: MAINARDES,RUBIANA M, et al.
Publicado: (2009) -
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
por: Jiang Y, et al.
Publicado: (2019)